Would you use biologic in combination with sibeprenlimab in a patient with IgA nephropathy with inflammatory arthritis?

Sibeprenlimab is a new FDA-approved humanized IgG2 monoclonal antibody designed to treat adults with primary immunoglobulin A nephropathy (IgAN)